Test Price
900 AED✅ Home Collection Available
Malaria Multiplex (P. falciparum, P. vivax, P. ovale & P. malariae) RNA Detection & Differentiation Test
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Real-Time RT-PCR + Whole Genome Sequencing).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Oversight: Post-test telephonic guidance and result interpretation provided by DHA-licensed professionals under the supervision of Dr. Ajay Singh.
- Insurance & Billing: Direct billing verification and insurance pre-approval available via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced molecular diagnostic assay employs Real-Time Reverse Transcription Polymerase Chain Reaction (RT‑qPCR) coupled with Whole Genome Sequencing (WGS) to detect and definitively differentiate all four major human malaria species: Plasmodium falciparum, P. vivax, P. ovale, and P. malariae. The test achieves a clinical sensitivity of 99.9% and is capable of identifying parasitemia levels as low as 1–5 parasites per microliter, significantly outperforming conventional microscopy and rapid diagnostic tests (RDTs).
| Parameter | Our Test (RNA Multiplex) | Closest Alternative (Rapid Antigen Test / Microscopy) |
|---|---|---|
| Precision & Sensitivity | 99.9% sensitivity; species-level differentiation confirmed via WGS; detects 1–5 parasites/µL | 60–85% sensitivity; may miss low parasitemia; limited species identification capability |
| Core Technology | Real-Time RT-PCR (qPCR) + Whole Genome Sequencing (WGS) | Microscopy (thick/thin smear) or immunochromatographic RDT (HRP2 / pLDH) |
| Turnaround Time (TAT) | Results available within 36 hours (phone) to 48 hours (email) | Microscopy: 1–2 hours; RDT: 15–30 minutes (however, accuracy is significantly lower) |
Physician Insight & Safety Protocols
Dr. Ajay Singh (General Practitioner | DHA Registration ID: 36234132) notes:
“As a DHA-licensed general practitioner, I regard this multiplex RNA assay as a best-in-class diagnostic tool for suspected malaria, particularly in returning travelers or febrile patients with unclear exposure history. The species-level resolution directly informs targeted antimalarial therapy. However, this molecular test must always be interpreted alongside clinical presentation, complete blood count, and standard blood film microscopy. In severe or complicated malaria—characterized by confusion, jaundice, or acute kidney injury—empiric treatment should never be delayed pending molecular results.”Safety & Exclusion Criteria
- Home Collection Exclusion: Mobile phlebotomy is not suitable for patients with known severe coagulopathy, hemodynamic instability, or those unable to provide informed consent. A physician referral is mandatory for home service eligibility.
- Emergency Red Flags: Patients experiencing confusion, seizures, severe pallor (anemia), reduced urine output (acute kidney injury), or jaundice must seek immediate emergency medical attention and should not wait for test results.
- Pre-Test Requirement: A signed consent form and detailed clinical history (travel within the last 12 months, fever pattern, prior antimalarial use) are required. No fasting is necessary.
Patient FAQ & Clinical Guidance
1. What is the Malaria Multiplex RNA test and how does it work?
This test detects and differentiates the RNA of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae using real-time RT-PCR technology. A small sample of your peripheral whole blood is collected. Our ISO 9001:2015 accredited laboratory extracts parasitic RNA, amplifies conserved genetic targets, and confirms the species via Whole Genome Sequencing (WGS). This process provides definitive species identification within 48 hours.
2. How does this test compare to a standard blood smear or rapid test?
Conventional microscopy and rapid diagnostic tests (RDTs) can miss low-level infections and often cannot differentiate between species. Our PCR-based RNA detection identifies as few as 1–5 parasites per microliter and provides a precise species diagnosis, enabling your physician to prescribe the most effective antimalarial medication without delay.
3. Can I take this test at home and how long do results take?
Yes, our DHA-licensed VIP mobile phlebotomy service is available 7 days a week from 8 AM to 11 PM. Your sample is collected using a temperature-controlled cold-chain kit to preserve RNA integrity. Results are communicated via telephone within 36 hours and via email within 48 hours, followed by telephonic clinical guidance from a qualified professional.
4. What do I need to do to prepare for the test?
No fasting or special preparation is required. However, you must provide a signed consent form and a complete clinical history, including details of recent travel to malaria-endemic regions, current symptoms (especially fever patterns), and any prior antimalarial treatment. This information is critical for accurate result interpretation and clinical correlation.
UAE Regulatory & Data Privacy Adherence
Regulatory Framework: This diagnostic service and all associated data handling procedures comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols strictly adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Quality Accreditations: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 1143
Clinical Governance: All test reports and post-test guidance are reviewed and authorized by Dr. Ajay Singh (General Practitioner | DHA Registration ID: 36234132), ensuring compliance with the highest standards of clinical accuracy and patient privacy.
Clinical & Logistical Metadata
| Test Name | Malaria Multiplex (P. falciparum, P. vivax, P. ovale & P. malariae) RNA Detection & Differentiation |
| Price (AED) | 900 |
| Turnaround Time | 36 Hours (Phone) / 48 Hours (Email) |
| Sample Type / Matrix | Whole Blood (Peripheral Venous) – Temperature-Controlled Cold-Chain Transport |
| Methodology Used | Real-Time Reverse Transcription Polymerase Chain Reaction (RT‑qPCR) & Whole Genome Sequencing (WGS) |
| ICD-10-CM Code | B50.9, B51.9, B52.9, B53.0 |
| LOINC Code | 47515-5 |
| DHA Facility License & Laboratory Address | 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians